Genomics & Omics Analysis - software & AI news

Daily news on software, AI, and companies shaping genomics & omics analysis.

Showing 47 results
DNA sample on a laboratory bench

Jun 2, 2026

Europe’s Next-Generation Sequencing Market Is Entering a New Era of Genomic Innovation

Europe is on the brink of a genomic revolution, driven by advancements in Next-Generation Sequencing (NGS) technologies that are reshaping healthcare toward personalized medicine.The integration of NGS into healthcare systems across Europe is transforming diagnostics and treatment strategies. With significant investments from governments, academic institutions, and biotechnology firms, the European NGS market is projected to surge from approximately $2.43 billion in 2025 to around $13.94 billion
A mass spectrometer in a research lab

May 31, 2026

Is Thermo Fisher (TMO) Turning AI-Enabled Orbitraps Into a Durable Edge in Life Sciences Tools?

Thermo Fisher Scientific recently unveiled its advanced Orbitrap Tribrid Apex and Orbitrap Excedion mass spectrometers at the ASMS Conference, showcasing significant advancements in sensitivity, speed, and compound detection for complex research applications in multiomics and pharmaceuticals.The integration of these new Orbitrap systems with Thermo Fisher's Olink proteomics and AI-driven software solutions aims to streamline the transition from discovery-scale data to regulatory-ready analysis a
A blood test vial representing AI-driven diagnostics in women's health

May 28, 2026

AWHL: AI-driven diagnostics improve detection and reduce surgeries in women's health

AI technologies are significantly enhancing diagnostic capabilities in women's health, particularly for conditions like ovarian cancer and endometriosis.Recent advancements in AI-driven, multi-omic diagnostics are poised to benefit over 10 million women by providing innovative blood tests that improve the accuracy of detection for these conditions. This technological shift not only enhances patient care but also aims to minimize unnecessary surgical procedures, which can carry various risks and
Flat illustration of microRNA and protein biomarkers

May 27, 2026

Aspira Women’s Health and Cleveland Clinic Expand Collaboration on AI-Powered Diagnostics for Ovarian Cancer and Endometriosis

Aspira Women’s Health has partnered with Cleveland Clinic to enhance AI-driven diagnostics aimed at ovarian cancer and endometriosis. This collaboration seeks to leverage advanced biomarker discovery and analytical models to improve women’s health diagnostics.The partnership will focus on developing non-invasive tests, building on Aspira's existing OvaSuite, which helps assess ovarian cancer risk for over a million American women annually. Plans include expanding their diagnostic offerings by in
Minimalist illustration of a heart valve and blood vessel

May 27, 2026

Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June

Cardio Diagnostics Holdings, Inc. is set to showcase its innovative cardiovascular solutions at four key national benefits conferences this June, addressing the critical issue of cardiovascular disease (CVD), a leading cost driver for health plans.The company will present its advanced blood tests, Epi+Gen CHD™ and PrecisionCHD™, which utilize a combination of epigenetics, genetics, and artificial intelligence to identify individuals at risk for severe cardiac events. These tests aim to enhance p
A minimalist illustration of a lymph node and a cancer cell in a dark palette.

May 26, 2026

Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing

Caris Life Sciences has launched the "Behind the Diagnosis" campaign to highlight the transformative impact of its genomic testing on patient care.The inaugural story features Erika Rios, whose initial diagnosis of stage 4 metastatic triple-negative breast cancer was corrected through Caris GPSai, an AI-driven tissue-of-origin model. This innovative tool revealed her actual condition as Hodgkin lymphoma, a significantly more treatable cancer. The case underscores the importance of accurate molec
A petri dish with a biological sample on a lab bench

May 26, 2026

Insilico Medicine and Human Longevity Announce Collaboration to Co-Develop Industry-First AI Foundation Model for Longevity Science

Insilico Medicine and Human Longevity have embarked on a groundbreaking collaboration to develop the first large-scale AI foundation model focused on human longevity science.This partnership aims to harness the power of artificial intelligence to decode the biological mechanisms of aging, with the goal of enhancing predictive healthcare. The global longevity market, currently valued at approximately $5.3 trillion, is expected to reach $8 trillion by 2030, driven by advancements in AI-driven drug
A stethoscope and blood pressure cuff in a clinical setting

May 18, 2026

Cardio Diagnostics Holdings (NASDAQ: CDIO) Offers Broad Suite of AI-Powered Solutions for Cardiovascular Disease Prevention

Cardio Diagnostics Holdings is addressing the critical need for early detection and intervention in cardiovascular disease through a comprehensive suite of AI-powered solutions.Recent research highlights the pressing need for advanced tools that can identify cardiovascular disease (CVD) risks earlier, which is vital for personalized intervention strategies. Cardio Diagnostics Holdings (CDIO) is responding by developing a range of solutions that leverage artificial intelligence, epigenetics, and
A genomic sample on a lab bench with imaging equipment in the background.

May 18, 2026

MedGenome to expand integrated diagnostics access across Mumbai suburbs

MedGenome has announced a strategic collaboration with Siddhi Diagnostics & Research Centre (SDRC) to enhance access to integrated diagnostics in the suburban areas of Mumbai. This partnership aims to combine genomics with advanced imaging technologies, thereby improving precision diagnostics in regions that traditionally lack such resources.MedGenome, known for its focus on genomics-driven diagnostics, is poised to strengthen its presence in the Mumbai suburbs through this collaboration. SDRC,
VO2 Max testing device in a clinical setting

May 14, 2026

Year-Long Preventive Health Programs

Fountain Life has introduced the APEX Membership, a comprehensive year-long preventive health initiative integrating advanced diagnostics and AI technology.This program includes a variety of assessments such as full body and brain MRIs, low-dose lung CTs, retinal scans, whole genome sequencing, and more. Notably, it features two new services: Functional Movement and Mobility Range Assessment, which utilize 3D motion capture and clinical-grade VO2 Max testing. These additions aim to fill a crucia
A minimalist trophy silhouette representing the MedTech Award in a dark color scheme.

May 11, 2026

MedTech Award Highlights Healthcare Informatics Breakthrough

The recent MedTech Award highlights a significant advancement in healthcare informatics, particularly through Ambry's CARE platform, which has garnered attention for its role in enhancing patient care and operational efficiency.Ambry was awarded this prestigious recognition on May 7, 2026, selected from over 4,700 global entries. This accolade is seen as a validation of the platform's effectiveness in improving patient outcomes, which is increasingly important in a competitive market. The award
Stylized DNA helix and test tube illustration

May 11, 2026

Stronger Q1 Results And New AI Oncology Tests Could Be A Game Changer For Caris Life Sciences (CAI)

Caris Life Sciences has reported impressive first-quarter results, showcasing a significant revenue increase and the launch of new AI-driven oncology tests that could reshape its market position.In May 2026, Caris Life Sciences announced a revenue of $216.17 million for Q1, a substantial rise from $120.92 million in the same period last year. The company also improved its net loss to $0.51 million and received MolDX approval for its Caris ChromoSeq whole genome assay. Additionally, it launched t